News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,417 Results
Type
Article (2675)
Company Profile (45)
Press Release (37697)
Section
Business (14969)
Career Advice (83)
Deals (2248)
Drug Delivery (9)
Drug Development (4345)
Employer Resources (10)
FDA (495)
Job Trends (839)
News (21475)
Policy (1159)
Tag
Academia (160)
Alliances (3643)
Alzheimer's disease (51)
Antibody-drug conjugate (ADC) (10)
Approvals (497)
Bankruptcy (12)
Best Places to Work (525)
Biosimilars (9)
Biotechnology (34)
Breast cancer (14)
Cancer (95)
Career advice (69)
CAR-T (8)
Cell therapy (26)
Clinical research (3330)
Collaboration (64)
Compensation (29)
COVID-19 (180)
C-suite (18)
Data (72)
Diagnostics (529)
Earnings (4481)
Events (6208)
Executive appointments (57)
FDA (528)
Funding (59)
Gene editing (10)
Gene therapy (11)
GLP-1 (57)
Government (168)
Healthcare (772)
Infectious disease (183)
Inflammatory bowel disease (10)
Intellectual property (9)
Interviews (9)
IPO (1056)
Job creations (320)
Job search strategy (66)
Layoffs (35)
Legal (232)
Lung cancer (14)
Manufacturing (19)
Medical device (366)
Medtech (366)
Mergers & acquisitions (1235)
Metabolic disorders (22)
Neuroscience (86)
NextGen: Class of 2025 (375)
Non-profit (174)
Northern California (255)
Obesity (9)
Opinion (16)
Patents (13)
People (5807)
Phase I (1385)
Phase II (1655)
Phase III (952)
Pipeline (39)
Postmarket research (32)
Preclinical (595)
Radiopharmaceuticals (13)
Rare diseases (13)
Real estate (485)
Regulatory (850)
Research institute (152)
Resumes & cover letters (11)
Schizophrenia (11)
Series A (16)
Southern California (261)
Startups (506)
United States (1237)
Vaccines (22)
Weight loss (8)
Date
Today (18)
Last 7 days (63)
Last 30 days (156)
Last 365 days (2712)
2025 (65)
2024 (2760)
2023 (3040)
2022 (3948)
2021 (4312)
2020 (3718)
2019 (2307)
2018 (1730)
2017 (1926)
2016 (1790)
2015 (1994)
2014 (1480)
2013 (1318)
2012 (1539)
2011 (1460)
2010 (1282)
Location
Africa (48)
Arizona (13)
Asia (2002)
Australia (337)
California (593)
Canada (108)
China (27)
Colorado (12)
Connecticut (12)
Europe (4107)
Florida (32)
Illinois (14)
Indiana (26)
Kansas (12)
Maryland (19)
Massachusetts (200)
Minnesota (15)
New Jersey (34)
New York (36)
North Carolina (78)
Northern California (255)
Ohio (21)
Pennsylvania (27)
South America (53)
Southern California (261)
Texas (45)
Washington State (33)
40,417 Results for "sola biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
SOLA Biosciences Presents Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS, at Neuroscience 2023 and ALS One Symposium
As a pioneer in innovative chaperone technology, SOLA Biosciences Inc. will present its compelling preclinical proof-of-concept data for SOL-257, a targeted gene therapy for misfolded TDP-43 in Amyotrophic Lateral Sclerosis, at Neuroscience 2023 in Washington, D.C. on November 15 and the ALS One Symposium on November 17.
November 9, 2023
·
2 min read
Genetown
SOLA Biosciences Shares Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS at 22nd Annual NEALS Meeting
SOLA Biosciences, a pioneer in innovative chaperone technology, will present its encouraging preclinical proof-of-concept data for SOL-257, a targeted gene therapy for misfolded TDP-43 in ALS, at the 22nd Annual Northeast ALS Consortium (NEALS) Meeting held in Florida on October 5.
October 3, 2023
·
2 min read
Press Releases
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
January 7, 2025
·
2 min read
Press Releases
Michael Scholle Appointed CEO of Tango Biosciences
January 7, 2025
·
2 min read
Press Releases
Genflow Biosciences PLC Announces 2024 Highlights
January 6, 2025
·
7 min read
Press Releases
Ensysce Biosciences Issues Annual Shareholder Letter
January 9, 2025
·
12 min read
Biotech Beach
Vektor Medical Secures $16 Million Series A Funding
Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital Life Science.
February 5, 2024
·
4 min read
Press Releases
Canyon Labs Announces Strategic Acquisition of iuvo BioScience’s Lab Services and Consulting Businesses to Expand End-to-End Development Solutions
January 7, 2025
·
5 min read
Press Releases
Nasdaq Grants Revelation Biosciences Inc. Continued Listing
January 6, 2025
·
5 min read
Press Releases
Solid Biosciences Added to the Nasdaq Biotechnology Index
December 24, 2024
·
1 min read
1 of 4,042
Next
